Eberhard Heymann
Impact in
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Enzyme function and inhibition 20
- Enzyme Catalysis and Immobilization 7
- Chemical Synthesis and Analysis 7
- Pharmacology 29
- Cholinesterase and Neurodegenerative Diseases 28
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Rolf Mentlein (25 shared papers)K Krisch (13 shared papers)Wolfgang Junge (8 shared papers)Wilhelm P. Neumann (7 shared papers)Alfred C. Feller (4 shared papers)Meinolf Suttorp (1 shared paper)Ernst Brandt (2 shared papers)O. v. Deimling (2 shared papers)
- Journals
- European Journal of Biochemistry (7 papers)Archives of Biochemistry and Biophysics (6 papers)Biochemical Pharmacology (5 papers)Biochemical Journal (3 papers)FEBS Letters (3 papers)
- Partner nations
- GermanyUnited StatesNorway
In The Last Decade
Eberhard Heymann
67 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 817
- Pharmacology 268
- Oncology 765
- Cellular and Molecular Neuroscience 489
- Computational Theory and Mathematics 408
Countries citing papers authored by Eberhard Heymann
This map shows the geographic impact of Eberhard Heymann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Heymann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Heymann more than expected).
Fields of papers citing papers by Eberhard Heymann
This network shows the impact of papers produced by Eberhard Heymann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Heymann. The network helps show where Eberhard Heymann may publish in the future.
Co-authors
The 25 scholars most cited alongside Eberhard Heymann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 177 | |
| 2 | 1980 | 147 | |
| 3 | 1982 | 131 | |
| 4 | 1978 | 124 | |
| 5 | 1990 | 113 | |
| 6 | 1967 | 105 | |
| 7 | 1984 | 96 | |
| 8 | 1984 | 88 | |
| 9 | 1987 | 84 | |
| 10 | 1990 | 79 | |
| 11 | 1979 | 77 | |
| 12 | 1979 | 75 | |
| 13 | 1980 | 74 | |
| 14 | 1969 | 73 | |
| 15 | 1981 | 68 | |
| 16 | 1985 | 65 | |
| 17 | 1988 | 60 | |
| 18 | 1984 | 58 | |
| 19 | 1973 | 51 | |
| 20 | 1974 | 50 |
About Eberhard Heymann
Eberhard Heymann is a scholar working on Molecular Biology, Pharmacology, Oncology, Computational Theory and Mathematics and Organic Chemistry, having authored 68 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (28 papers), Enzyme function and inhibition (20 papers), Peptidase Inhibition and Analysis (15 papers), Computational Drug Discovery Methods (13 papers), Neuropeptides and Animal Physiology (8 papers), Enzyme Catalysis and Immobilization (7 papers), Chemical Synthesis and Analysis (7 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Pharmacology (817 citations), Pharmacology (268 citations), Oncology (765 citations), Cellular and Molecular Neuroscience (489 citations) and Computational Theory and Mathematics (408 citations). Eberhard Heymann has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Rolf Mentlein, K Krisch, Wolfgang Junge, Wilhelm P. Neumann, Alfred C. Feller, Meinolf Suttorp, Ernst Brandt, O. v. Deimling, Wolfgang Scholz and H.‐D. Flad. Their work appears in journals such as European Journal of Biochemistry, Archives of Biochemistry and Biophysics, Biochemical Pharmacology, Biochemical Journal and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.